Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s traded shares stood at 1.02 million during the last session, with the company’s beta value hitting 1.29. At the close of
Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s traded shares stood at 1.08 million during the last session, with the company’s beta value hitting 1.28. At the close of
In last trading session, Checkpoint Therapeutics Inc (NASDAQ:CKPT) saw 0.72 million shares changing hands with its beta currently measuring 1.27. Company’s recent per share price
Checkpoint Therapeutics Inc (NASDAQ:CKPT) has a beta value of 1.28 and has seen 1.1 million shares traded in the last trading session. The company, currently
During the last session, Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s traded shares were 1.65 million, with the beta value of the company hitting 1.30. At the end
During the last session, Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s traded shares were 2.39 million, with the beta value of the company hitting 1.31. At the end
In the last trading session, 2.1 million shares of the Checkpoint Therapeutics Inc (NASDAQ:CKPT) were traded, and its beta was 1.31. Most recently the company’s
Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s traded shares stood at 2.03 million during the last session, with the company’s beta value hitting 1.29. At the close of
Checkpoint Therapeutics Inc (NASDAQ:CKPT)’s traded shares stood at 0.61 million during the latest session, with the company’s beta value hitting 1.29. At the last check
In the last trading session, 1.16 million Checkpoint Therapeutics Inc (NASDAQ:CKPT) shares changed hands as the company’s beta touched 1.32. With the company’s per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
